John Harris compensation by year
Integer Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $419,395 |
| Bonus | $0 |
| Stock awards | $1,044,797 |
| Option awards | $0 |
| Non-equity incentive | $313,792 |
| Pension and deferred compensation | $0 |
| All other | $89,498 |
| Total | $1,867,482 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Integer Holdings Corp DEF 14A filed April 7, 2025, accession 0001114483-25-000075, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Integer Holdings Corp filed document, accession 0001114483-25-000075. Every figure is read from that document and cited to the page and table it appears in. Filed April 7, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 7,176 | $950,964 | — |
| RSU | 5,396 | $715,078 | — |
| RSU | 3,837 | $508,479 | — |
| RSU | 1,907 | $252,716 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Integer Holdings Corp's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
18 Form 4 lines since the FY2024 proxy (filed April 7, 2025)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-13 | Exercise or conversion | — | 5,458 | — | 14,115 |
| 2026-11-13 | Grant or award | — | 3,282 | — | 17,397 |
| 2026-11-13 | Exercise or conversion derivative | — | 5,458 | — | 5,458 |
| 2026-11-13 | Disposition to the issuer derivative | — | 5,458 | — | 0 |
| 2026-11-13 | Tax withholding | — | 4,199 | $126.70 | 13,198 |
| 2026-11-13 | Disposition to the issuer | — | 13,198 | — | 0 |
| 2026-06-29 | Grant or award derivative | — | 1,096 | $0.00 | 1,096 |
| 2026-03-31 | Exercise or conversion | — | 3,837 | — | 10,499 |
The 8 most recent of 18 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Integer’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Joseph Dziedzic | Former President and CEO | $8,675,379 |
| Diron Smith | Executive Vice President and Chief Financial Officer | $2,472,797 |
| Payman Khales | President, Cardio & Vascular | $1,976,810 |
| John Harris · this page | Executive Vice President, Global Operations and Manufacturing Strategy | $1,867,482 |
| Jim Stephens | President, Cardiac Rhythm Management & Neuromodulation | $1,600,604 |
The full Integer compensation record
free company briefThis page is one person within Integer's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Integer proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Integer's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.